Association between remifentanil and acute kidney injury

Journal of Anesthesia, Jan 2018

Seokha Yoo, Karam Nam, Won Ho Kim

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

Association between remifentanil and acute kidney injury

Journal of Anesthesia Association between remifentanil and acute kidney injury Seokha Yoo 0 Karam Nam 0 Won Ho Kim 0 To the Editor: 0 0 Department of Anesthesiology and Pain Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 , Korea - We would like to discuss the methodological issues of the interesting study by Sakai et al. [ 1 ]. To prove an association and causal relationship between a potential predictor and an outcome variable, Hill’s criteria should be met [ 2, 3 ]. The criteria include strength, consistency, specificity, temporality, biological gradient (dose–response relationship), biological plausibility, coherence, experiment, and analogy. For example, as the remifentanil could result in vasodilation and increase in renal perfusion via suppression of vasopressin, there is a physiologic plausibility for remifentanil to decrease the risk of acute kidney injury (AKI). However, a significant association was not found, possibly due to small sample size. Regarding the dose–response relationship, the author’s analysis seems to be insufficient. The remifentanil administration was evaluated only as a binomial variable in the multivariate analysis. The distribution of three different dose categories was shown in Fig. 2. The dose–response relationship could be analyzed by adding these three dose categories to the multivariate analysis, Or, if the data on the remifentanil dose were available as a continuous variable, the dose of remifentanil as a continuous variable could be added to the multivariate analysis in their study or in a further prospective trial. Compliance with ethical standards Conflict of interest No competing interest declared. 1. Sakai W , Yoshikawa Y , Hirata N , Yamakage M. Effect of remifentanil during cardiopulmonary bypass on incidence of acute kidney injury after cardiac surgery . J Anesth . 2017 ; 31 : 895 - 902 . 2. Hill AB . The environment and disease: association or causation? Proc R Soc Med . 1965 ; 58 : 295 - 300 . 3. Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery . Br J Anaesth . 2012 ; 109 ( Suppl 1 ): i29 - 38 .

This is a preview of a remote PDF:

Seokha Yoo, Karam Nam, Won Ho Kim. Association between remifentanil and acute kidney injury, Journal of Anesthesia, 2018, 1-1, DOI: 10.1007/s00540-018-2450-7